Treatment Options for Gout
The management of gout requires a three-pronged approach: treatment of acute flares with oral colchicine, NSAIDs, or glucocorticoids; urate-lowering therapy with medications like allopurinol; and lifestyle modifications to reduce risk factors. 1
Treatment of Acute Gout Flares
First-line Options
Oral colchicine: Most effective when started within 12 hours of symptom onset
- Recommended dosing: 1.2 mg initially, followed by 0.6 mg one hour later 1
- For patients with renal impairment:
NSAIDs:
Corticosteroids:
Adjunctive Therapy
- Topical ice application 1
- For severe polyarticular involvement, consider combination therapy (e.g., NSAIDs + colchicine) 1
Urate-Lowering Therapy (ULT)
Indications for ULT
- Recurrent gout attacks (≥2 per year)
- Presence of tophi
- Joint damage
- Chronic kidney disease 1
Medication Options
Allopurinol (first-line):
- Starting dose: 100 mg daily (lower in renal insufficiency)
- Increase by 100 mg weekly
- Target serum uric acid level: < 6 mg/dL
- Typical maintenance dose: 200-600 mg/day depending on severity 1
Febuxostat:
- Alternative first-line if allopurinol is not tolerated or contraindicated 1
Probenecid:
- First choice among uricosurics
- Can be combined with xanthine oxidase inhibitors for refractory cases 1
Prophylaxis During ULT Initiation
- Colchicine 0.5-1.0 mg daily for first 6 months of ULT to prevent paradoxical flares 1
- Alternative options: low-dose NSAIDs or corticosteroids 3
Lifestyle Modifications
- Weight loss for overweight/obese patients 1
- Dietary modifications:
- Hydration: At least 2 liters daily 1
- Regular moderate physical activity 1
Special Considerations
Renal Impairment
- Assess renal function before initiating therapy 1
- Avoid NSAIDs and colchicine if eGFR < 30 ml/min 1
- For allopurinol in severe renal failure: Start at 0.3 mg/day with careful monitoring 2
Hepatic Impairment
- For mild to moderate impairment: No dose adjustment required for acute treatment, but monitor closely
- For severe impairment: Treatment course should not be repeated more than once every two weeks 2
Pregnancy
- Oral, intramuscular, or intra-articular glucocorticoids are recommended for acute attacks 1
- Options include prednisone 30-35 mg daily for 3-5 days or intra-articular injections 1
Common Pitfalls to Avoid
Medication interactions: Strong CYP3A4 inhibitors (clarithromycin, ketoconazole) require colchicine dose reductions to prevent toxicity 1
Missing early signs of colchicine toxicity: Monitor for gastrointestinal symptoms 1
Inadequate monitoring: Regular serum uric acid level checks are necessary to ensure target levels are maintained 1
Insufficient duration of ULT: Treatment should continue for at least 3 months after uric acid levels fall below target in those without tophi, and 6 months in those with tophi 3
Failure to provide prophylaxis when initiating ULT, which can trigger acute flares 1, 3